A study of the IDIBELL and ICO team on infections and cancer, in collaboration with WHO and UNICEF, has analyzed the rate of vaccinations around the world. They found that, while there is still a long way and many challenges ahead, there are a few countries that have already achieved it. Therefore it is an acceptable goal.
Cervical cancer, cancer that we can eliminate Read More »
We spoke with Dr. Xavier Bosch, principal investigator of the IDIBELL infection and cancer research group, doctor at the ICO, professor at the UOC, and expert in the vaccine against HPV (human papillomavirus), on the challenge of large-scale vaccination against COVID-19 and the reticence that this whole process is generating.
During the project, a digital escape room will be co-created in coordination with teachers, students, researchers, and science communicators.
A study from IDIBELL and ICO has shown that telehealth systems can be applied to detect early complications after a bone marrow transplant, both physical and psychological.
According to a study carried out by researchers from the EPIBELL Program of IDIBELL and the Cancer Screening Unit of ICO Hospitalet, in the period from 2017 to 2018, among 643 pharmacies affiliated with the Official College of Pharmacists, 528 were members of the Program, which corresponds to 85.4% of the total.
To commemorate the International Day of Women and Girls in Science, IDIBELL organizes an event where 8 women will explain through an informative talk their work in research and innovation.
Women in science: the 4th sLHam of women scientist of IDIBELL arrives Read More »
The algorithm, based on data from about 20,000 patients, will facilitate the choice of the best therapeutic option to avoid new episodes of heart failure
The study led by ICO and IDIBELL and UCSF describes, thanks to Big Data analysis, a control mechanism for DNA repair that would sensitize tumors to therapy.
A universal weakness of solid tumors opens the door to cancer treatment improvement Read More »
A research group from IDIBELL has published in the journal Blood their discoveries about the cellular mechanisms responsible for stopping tumor growth by blocking the formation of new ribosomes.
At IDIBELL, we join in the visualization of women and girls in science on February 11. Over the next few days, we will organize seminars, campaigns on social networks and, we will celebrate the 4th sLHam of women scientists.
IDIBELL celebrates the International Day of Women and Girls in Science Read More »
